The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This pilot study aims to address whether the prophylactic use of Cetrorelix Acetate after a
long gonadotropin-releasing hormone (GnRH) agonist protocol post-hCG (human chorionic
gonadotropin) administration can significantly reduce the incidence of OHSS in oocyte donors.